<DOC>
	<DOCNO>NCT00814463</DOCNO>
	<brief_summary>RATIONALE : Stereotactic radiosurgery may able send x-ray directly tumor cause less damage normal tissue . Giving stereotactic radiosurgery surgery may kill tumor cell remain surgery . PURPOSE : This phase II trial study well stereotactic radiosurgery work treat patient brain metastasis .</brief_summary>
	<brief_title>Stereotactic Radiosurgery After Surgery Treating Patients With Brain Metastases</brief_title>
	<detailed_description>OBJECTIVES : Primary - To estimate rate recurrence surgical site patient brain metastasis treat adjuvant stereotactic radiosurgery ( SRS ) compare historical data document recurrence surgical site surgery whole brain radiotherapy ( WBRT ) . Secondary - To estimate rate salvage WBRT , SRS , surgery patient treat adjuvant SRS alone . - To estimate rate new brain metastasis outside adjuvant SRS site . - To estimate patient quality life adjuvant SRS alone . - To assess effect surgical intervention SRS preservation neurocognitive functioning patient . - To determine clinical significance ( ) locally recurrent brain metastasis time occurrence ( mass effect , cognitive functioning , symptom ) patient . - To estimate rate death due neurologic cause , define death attributable progression neurological disease . - To estimate overall survival patient . OUTLINE : Patients undergo stereotactic radiosurgery 30-90 minute . Quality life neurocognitive function assess periodically . After completion study therapy , patient follow every 3 month 1 year every 6 month 1 year .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>1 . Age &gt; 18 year age . 2 . Gross total resection ( verified lack enhancement resection cavity postoperative MRI ) single brain metastasis confirm histology . Patients 4 metastasis eligible large mass amenable surgical resection nonresected mass amenable SRS . 3 . Patient must Radiation Therapy Oncology Group ( RTOG ) recursive partition analysis ( RPA ) Class 1 2 . 4 . Life expectancy least 3 month . 1 . Radiographic cytologic evidence leptomeningeal disease . 2 . Patient incomplete partial resection . 3 . Primary lesion radiosensitive histology ( i.e. , small cell carcinoma , germcell tumor , lymphoma , leukemia , multiple myeloma ) . 4 . Patients resection cavity &gt; 4 cm maximal extent plane contrast MRI scan . 5 . Lesion locate anatomic region amenable SRS include brain stem optic apparatus . 6 . Pregnant need breast feed study period . 7 . Uncontrolled intercurrent illness include , limited symptomatic congestive heart failure , unstable angina pectoris , psychiatric illness . 8 . Brain surgery resection metastasis . 9 . Previous brain radiotherapy . 10 . Contraindication SRS , WBRT , MRI .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>tumor metastatic brain</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>